Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Pavlakis

Showing results (211-220 of 294) with videos related to

Pageof 30
Sort By:
Current Oncology (Toronto, Ont.)|January 5, 2019
Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment responseS Sud, C O'Callaghan, C Jonker, et al.
Biomaterials|August 15, 2016
Efficient production and enhanced tumor delivery of engineered extracellular vesiclesDionysios C Watson, Defne Bayik, Avinash Srivatsan, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaquesAgneta S von Gegerfelt, Candido Alicea, Antonio Valentin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 10, 2022
Defining the rate of nutritional and metabolic derangements after pancreatic resectionK L Percy, Y X Ooi, C B Nahm, et al.
Frontiers in Immunology|August 8, 2022
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV <i>gag</i> conserved elements in macaquesAntonio Valentin, Cristina Bergamaschi, Margherita Rosati, et al.
Journal for Immunotherapy of Cancer|October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumorsRom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Vaccine|January 4, 2011
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesViraj Kulkarni, Rashmi Jalah, Brunda Ganneru, et al.
Human Vaccines & Immunotherapeutics|August 17, 2012
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesRashmi Jalah, Vainav Patel, Viraj Kulkarni, et al.
Frontiers in Immunology|June 13, 2022
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological MalignanciesCristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2015
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPenelope E Schofield, M R Stockler, D Zannino, et al.
Pageof 30

Showing results (211-220 of 294) with videos related to

Sort By:
Pageof 30
Current Oncology (Toronto, Ont.)|January 5, 2019
Hypertension as a predictor of advanced colorectal cancer outcome and cetuximab treatment responseS Sud, C O'Callaghan, C Jonker, et al.
Biomaterials|August 15, 2016
Efficient production and enhanced tumor delivery of engineered extracellular vesiclesDionysios C Watson, Defne Bayik, Avinash Srivatsan, et al.
AIDS Research and Human Retroviruses|June 27, 2006
Long lasting control and lack of pathogenicity of the attenuated Rev-independent SIV in rhesus macaquesAgneta S von Gegerfelt, Candido Alicea, Antonio Valentin, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 10, 2022
Defining the rate of nutritional and metabolic derangements after pancreatic resectionK L Percy, Y X Ooi, C B Nahm, et al.
Frontiers in Immunology|August 8, 2022
Comparative immunogenicity of an mRNA/LNP and a DNA vaccine targeting HIV <i>gag</i> conserved elements in macaquesAntonio Valentin, Cristina Bergamaschi, Margherita Rosati, et al.
Journal for Immunotherapy of Cancer|October 31, 2023
First-in-human phase I/Ib study of NIZ985, a recombinant heterodimer of IL-15 and IL-15Rα, as a single agent and in combination with spartalizumab in patients with advanced and metastatic solid tumorsRom Leidner, Kevin Conlon, Douglas G McNeel, et al.
Vaccine|January 4, 2011
Comparison of immune responses generated by optimized DNA vaccination against SIV antigens in mice and macaquesViraj Kulkarni, Rashmi Jalah, Brunda Ganneru, et al.
Human Vaccines & Immunotherapeutics|August 17, 2012
IL-12 DNA as molecular vaccine adjuvant increases the cytotoxic T cell responses and breadth of humoral immune responses in SIV DNA vaccinated macaquesRashmi Jalah, Vainav Patel, Viraj Kulkarni, et al.
Frontiers in Immunology|June 13, 2022
Reduced Antibodies and Innate Cytokine Changes in SARS-CoV-2 BNT162b2 mRNA Vaccinated Transplant Patients With Hematological MalignanciesCristina Bergamaschi, Maria Pagoni, Margherita Rosati, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|June 22, 2015
Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancerPenelope E Schofield, M R Stockler, D Zannino, et al.
Pageof 30